Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Dal Ferro

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
ESC Heart Failure|September 23, 2020
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathyGiovanni Donato Aquaro, Antonio De Luca, Chiara Cappelletto, et al.
European Journal of Heart Failure|April 13, 2025
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathyEva Del Mestre, Alessia Paldino, Carola Pio Loco Detto Gava, et al.
The Canadian Journal of Cardiology|December 17, 2025
Predictors of Disease Progression in Patients with Left Ventricular Nondilated CardiomyopathyElena Bacigalupi, Marco Merlo, Giulia Barbati, et al.
Giornale Italiano Di Cardiologia (2006)|July 26, 2023
[Cardiac contractility modulation therapy: molecular mechanisms and rationale for clinical application in heart failure with systolic and diastolic dysfunction]Alberto Guarnaccia, Matteo Dal Ferro, Mauro Biffi, et al.
Human Molecular Genetics|June 8, 2018
Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutationMaria Chatzifrangkeskou, David Yadin, Thibaut Marais, et al.
Journal of the American College of Cardiology|September 14, 2019
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated CardiomyopathyMarta Gigli, Marco Merlo, Sharon L Graw, et al.
Scientific Reports|July 8, 2017
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathyElena Sommariva, Yuri D'Alessandra, Floriana Maria Farina, et al.
Journal of the American College of Cardiology|November 17, 2022
Prognostic Prediction of Genotype vs Phenotype in Genetic CardiomyopathiesAlessia Paldino, Matteo Dal Ferro, Davide Stolfo, et al.
Cardiovascular Research|November 15, 2023
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial FunctionMichele Ciccarelli, Inês Falcão Pires, Johann Bauersachs, et al.
Giornale Italiano Di Cardiologia (2006)|November 24, 2020
[Diagnostic work-up and clinical management of cardiomyopathies: the operative protocol from the Cardiothoracovascular Department of Trieste, Italy]Marco Merlo, Chiara Cappelletto, Giulia De Angelis, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
ESC Heart Failure|September 23, 2020
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathyGiovanni Donato Aquaro, Antonio De Luca, Chiara Cappelletto, et al.
European Journal of Heart Failure|April 13, 2025
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathyEva Del Mestre, Alessia Paldino, Carola Pio Loco Detto Gava, et al.
The Canadian Journal of Cardiology|December 17, 2025
Predictors of Disease Progression in Patients with Left Ventricular Nondilated CardiomyopathyElena Bacigalupi, Marco Merlo, Giulia Barbati, et al.
Giornale Italiano Di Cardiologia (2006)|July 26, 2023
[Cardiac contractility modulation therapy: molecular mechanisms and rationale for clinical application in heart failure with systolic and diastolic dysfunction]Alberto Guarnaccia, Matteo Dal Ferro, Mauro Biffi, et al.
Human Molecular Genetics|June 8, 2018
Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutationMaria Chatzifrangkeskou, David Yadin, Thibaut Marais, et al.
Journal of the American College of Cardiology|September 14, 2019
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated CardiomyopathyMarta Gigli, Marco Merlo, Sharon L Graw, et al.
Scientific Reports|July 8, 2017
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathyElena Sommariva, Yuri D'Alessandra, Floriana Maria Farina, et al.
Journal of the American College of Cardiology|November 17, 2022
Prognostic Prediction of Genotype vs Phenotype in Genetic CardiomyopathiesAlessia Paldino, Matteo Dal Ferro, Davide Stolfo, et al.
Cardiovascular Research|November 15, 2023
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial FunctionMichele Ciccarelli, Inês Falcão Pires, Johann Bauersachs, et al.
Giornale Italiano Di Cardiologia (2006)|November 24, 2020
[Diagnostic work-up and clinical management of cardiomyopathies: the operative protocol from the Cardiothoracovascular Department of Trieste, Italy]Marco Merlo, Chiara Cappelletto, Giulia De Angelis, et al.
Pageof 10